Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Quadratic Models01:23

Quadratic Models

Quadratic models are mathematical representations used to describe relationships in which the rate of change changes at a constant rate. These models appear in a wide variety of natural and engineered systems, especially those involving motion, forces, and optimization. One common application is analyzing the vertical motion of objects influenced by gravity, such as a ball thrown into the air.In such scenarios, the object's height changes over time in a curved pattern, rising to a maximum point...
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are observed.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nonparametric estimation of average effects of a continuous treatment for survival data with a cured fraction.

Lifetime data analysis·2026
Same author

Recommendations for studying the association of the cancer diagnosis to treatment interval with overall survival: a modified Delphi process.

British journal of cancer·2025
Same author

Marginal semiparametric accelerated failure time cure model for clustered survival data.

Statistical methods in medical research·2024
Same author

Mean residual life cure models for right-censored data with and without length-biased sampling.

Biometrical journal. Biometrische Zeitschrift·2023
Same author

The mean residual life model for the right-censored data in the presence of covariate measurement errors.

Statistics in medicine·2023
Same author

Measures of explained variation under the mixture cure model for survival data.

Statistics in medicine·2022
Same journal

Modeling treatment effects on absorbing outcomes in clinical trials: Leveraging longitudinal and ordinal data for efficiency gains.

Statistical methods in medical research·2026
Same journal

A joint model for a longitudinal outcome and a progressive multistate model under a mixed observation scheme.

Statistical methods in medical research·2026
Same journal

Efficient semi-supervised estimation of optimal individualized treatment regimes with survival outcome.

Statistical methods in medical research·2026
Same journal

Asymptotic online FWER control for dependent test statistics.

Statistical methods in medical research·2026
Same journal

Regression analysis of misclassified current status data with potentially unknown test accuracy.

Statistical methods in medical research·2026
Same journal

Bayesian multivariate linear mixed-effects models with varied association structures.

Statistical methods in medical research·2026
See all related articles

Related Experiment Video

Updated: May 25, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

A quantile cure model with partially functional covariate effects.

Chyong-Mei Chen1, Yingwei Peng2,3

  • 1Institute of Public Health, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan ROC.

Statistical Methods in Medical Research
|May 23, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces a new method for analyzing survival data with cure models using quantile regression. The approach offers double robustness and improved efficiency, revealing new insights into lung cancer survival times.

Keywords:
Estimating equationinverse probability censoring weightinglung cancermixture cure modelquantile regression model

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Related Experiment Videos

Last Updated: May 25, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Econometrics

Background:

  • Quantile regression is valuable for analyzing continuous outcomes, handling heteroscedasticity, and modeling covariate effects across quantiles.
  • Existing methods for mixture cure models often rely on restrictive assumptions, limiting their application and interpretability.
  • Previous analyses of lung cancer data were constrained by the limitations of traditional survival models.

Purpose of the Study:

  • To propose novel estimating equation approaches for mixture cure models using quantile regression for latency time.
  • To develop methods that offer double robustness and relax restrictive global log-linear assumptions.
  • To provide a more flexible and robust framework for survival data analysis.

Main Methods:

  • Developed estimating equation approaches for a mixture cure model incorporating quantile regression for latency.
  • Ensured double robustness, where misspecification in one component does not impact the other.
  • Relaxed global log-linear assumptions, allowing for quantile-varying and invariant effects.

Main Results:

  • Established asymptotic properties of the proposed estimators.
  • Simulation studies confirmed double robustness and efficiency gains compared to existing methods.
  • Application to lung cancer data identified significant survival differences between uncured patient groups.

Conclusions:

  • The proposed quantile regression-based mixture cure model offers a robust and flexible alternative for survival data analysis.
  • The method provides valuable insights, as demonstrated by its application to lung cancer data, revealing previously unreported survival differences.
  • This approach enhances the ability to model complex survival data, particularly in the presence of cure fractions and heteroscedasticity.